← Back to Bills
HR 1170118th CongressFailed / ExpiredHouse

Access to Future Cures Act

Policy Area: Taxation
View on Congress.gov
Origin Chamber
House
Last Updated
May 27, 2025
Latest Action Date
Dec 17, 2024

Latest Action

Referred to the Subcommittee on Health.

Official Summary

Official summary has not been imported yet.

GovScope Watchdog™

AI Government Intelligence™
Executive Summary

The Access to Future Cures Act (H.R. 1170) was introduced in the 118th Congress and referred to the Subcommittee on Health. The bill's summary and full text are not available, but it is categorized under the policy area of Taxation. The bill ultimately failed or expired without further legislative action.

Bottom Line

H.R. 1170, aimed at issues related to future cures and taxation, did not advance beyond subcommittee referral and expired without enactment.

Policy Risk Level
🟡 Medium
Neutral Risk Assessment
Key Points
  • The bill was introduced in the House during the 118th Congress.
  • It was referred to the Subcommittee on Health on December 17, 2024.
  • The bill is classified under the policy area of Taxation but lacks available summary or full text.
Who Benefits?

Due to the absence of bill text and summary, it is unclear who specifically would benefit; however, given the title and policy area, potential beneficiaries might include healthcare sectors, pharmaceutical companies, patients awaiting future cures, and tax-related stakeholders.

Potential Concerns

Without the bill text or summary, potential concerns cannot be fully assessed. General considerations for similar bills include implementation challenges, fiscal impact, regulatory authority, and oversight mechanisms.

Political Context

The bill was introduced and referred to a relevant subcommittee but did not progress further, indicating limited legislative momentum or prioritization within the 118th Congress. The lack of available summary or text limits detailed contextual analysis.

Hidden Impact Review

Hidden impact flags detected: 1

GovScope reviewed 1 policy-risk categories. Hover for a quick definition. Click detected flags for bill-specific details.

1 Detected
Detected Flags
Indirect Effects

If enacted, the bill could have influenced taxation policies related to healthcare innovation or pharmaceutical development, potentially affecting funding and access to medical cures. However, due to lack of text, specific indirect effects cannot be identified.

GovScope Watchdog Notes

The absence of publicly available bill text and summary highlights a transparency gap that impedes comprehensive analysis and public engagement. Monitoring such gaps is important for ensuring accountability and informed legislative processes.

Passage Likelihood: LowConfidence: 40%Model: gpt-4.1-mini

GovScope Intelligence Roadmap

Future bill intelligence will connect sponsors, committee referrals, related votes, campaign finance, disclosures, and stock trades into one legislative intelligence view.

Enterprise Ready